Items where Author is "103658"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2018 | 2017 | 2016 | 2015 | 2011 | 2010 | 2009 | 2006 | 2004 | 2003 | 2002 | 2001
Number of items: 29.

2018

2017

Foss, A; Locke, L; Lawrence, S; Marks, D; Makowiecka, K; Brammar, L; Woods, C; (2017) Raising awareness and recognition of creativity and innovation. [Conference or Workshop Item] Full text not available from this repository.

2016

Kestler, A; Buxton, J; Meckling, G; Giesler, A; Lee, M; Fuller, K; Quian, H; Marks, D; Scheuermeyer, F; (2016) Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users. Annals of emergency medicine. ISSN 0196-0644 DOI: https://doi.org/10.1016/j.annemergmed.2016.07.027 Full text not available from this repository.

2015

Lee, H; Leamon, S; Marks, D; MacDowall, W; Holdsworth, E; Datta, J; (2015) Improving self-management of diabetes and awareness of good eye health amongst the Pakistani population. Diabetic medicine, 32. p. 145. ISSN 0742-3071 Full text not available from this repository.

2011

2010

Marks, D; (2010) Evaluating the ethics of health promotion: acquiring informed consent. In: Thorogood, M; Coomes, Y, (eds.) Evaluating Health Promotion: practice and methods. 3rd ed. OUP, Oxford, UK. ISBN 978-0199569298
[img]

2009

Briggs, D; Rhodes, T; Marks, D; Kimber, J; Jones, S; Holloway, G; (2009) Injecting drug use, unstable housing: scope for structural interventions in harm reduction. Drugs (Abingdon, England), 16 (5). pp. 436-450. ISSN 0968-7637 DOI: https://doi.org/10.1080/09687630802697685 Full text not available from this repository.

Hadfield, SG; Horara, S; Starr, BJ; Yazdgerdi, S; Marks, D; Bhatnagar, D; Cramb, R; Egan, S; Everdell, R; Ferns, G; +11 more... (2009) Family tracing to identify patients with Familial Hypercholesterolaemia: the Second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Annals of clinical biochemistry, 46. pp. 24-32. ISSN 0004-5632 DOI: https://doi.org/10.1258/acb.2008.008094 Full text not available from this repository.

2006

2004

Marks, D; (2004) Evaluating the ethics of health promotion: acquiring informed consent. In: Thorogood, M; Coombes, Y, (eds.) Evaluating Health Promotion: practice and methods. Oxford University Press. Full text not available from this repository.

Marks, D; Thorogood, M; Farrer, JM; Humphries, SE; (2004) Census of clinics providing specialist lipid services in the United Kingdom. Journal of public health (Oxford, England), 26 (4). pp. 353-4. ISSN 1741-3842 DOI: https://doi.org/10.1093/pubmed/fdh176 Full text not available from this repository.

Wonderling, D; Umans-Eckenhausen, MA; Marks, D; Defesche, JC; Kastelein, JJ; Thorogood, M; (2004) Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands. Seminars in vascular medicine, 4 (1). pp. 97-104. ISSN 1528-9648 DOI: https://doi.org/10.1055/s-2004-822992 Full text not available from this repository.

2003

Marks, D; Boulton, MG; Thorogood, M; (2003) The Experience of Relatives of Individuals with Familial Hypercholesterolaemia: Social and Psychological Impact of Screening. Technical Report. Report prepared for the British Heart Foundation, London. Full text not available from this repository.

Marks, D; Thorogood, M; Farrer, JM; Humphries, SE; (2003) Census of clinics providing specialist lipid services in The British Isles. Atherosclerosis, 169 (2). p. 362. ISSN 0021-9150 Full text not available from this repository.

Marks, D; Thorogood, M; Neil, HA; Humphries, SE; (2003) A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis, 168 (1). pp. 1-14. ISSN 0021-9150 DOI: https://doi.org/10.1016/S0021-9150(02)00330-1 Full text not available from this repository.

2002

Wonderling, D; Umans-Eckenhausen, MAW; Marks, D; Defesche, JC; Kastelein, JJP; Thorogood, M; (2002) A cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands. [Conference or Workshop Item] Full text not available from this repository.

2001

Marks, D; Lambert, H; Thorogood, M; Neil, H; Humphries, S; Wonderling, D; (2001) Does screening for a modifiable genetic condition cause distress? Abundance of opinion and paucity of data' [abstract]. [Conference or Workshop Item] Full text not available from this repository.

Marks, D; Lambert, H; Thorogood, M; Neil, HAW; Humphries, SE; Wonderling, D; (2001) Does screening for a modifiable genetic condition cause stress?: abundance of opinion and paucity of data [Abstract 78]. Journal of epidemiology and community health, 55 (Supplement 1). A20-A21. ISSN 0143-005X Full text not available from this repository.

Marks, D; Thorogood, M; (2001) Screening options for Familial Hypercholesterolaemia: Comparing costs and benefits of two strategies over a ten year period. Technical Report. London School of Hygiene & Tropical Medicine, London. Full text not available from this repository.

This list was generated on Fri Jul 20 03:34:13 2018 BST.